Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parallel Group Randomized Controlled Trial to Assess the Impact of Medication Reconciliation at Hospital Admission on Healthcare Outcomes

NCT03654963 is registered in ClinicalTrials.gov with Ente Ospedaliero Cantonale, Bellinzona as lead sponsor.

NCT NCT03654963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03654963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parallel Group Randomized Controlled Trial to Assess the Impact of Medication Reconciliation at Hospital Admission on Healthcare Outcomes
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2018
Completion date
January 8, 2020
Enrollment
1,702 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues